Coma Diagnosis and Treatment Market Research Report- Global Forecast till 2027

Coma Diagnosis & Treatment Market Research Report: By Types (Toxic-Metabolic Encephalopathy, Anoxic Brain Injury), Diagnosis (Physical Examination, Brain Scans) Treatment (Medical Treatment), End User (Hospitals & Clinics) - Global Forecast till 2027

ID: MRFR/Pharma/3555-HCR | | Region: Global | 120 Pages         

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Coma Diagnosis & Treatment Market, by Type

6.1 Introduction

6.2 Toxic- metabolic encephalopathy

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Anoxic brain injury

6.3.1 Market Estimates & Forecast, 2020-2027

7. Global Coma Diagnosis & Treatment Market, by Diagnosis

7.1 Introduction

7.2 Physical examination

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Blood tests

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Brain Scans

7.4.1 Market Estimates & Forecast, 2020-2027

7.5 Others

7.5.1 Market Estimates & Forecast, 2020-2027

8. Global Coma Diagnosis & Treatment Market, by Treatment

8.1 Introduction

8.2 Medical Treatment

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Drugs

8.3.1 Market Estimates & Forecast, 2020-2027

9. Global Coma Diagnosis & Treatment Market, by End User

9.1 Introduction

9.2 Hospitals & clinics

9.2.1 Market Estimates & Forecast, 2020-2027

9.3 Research laboratories

9.3.1 Market Estimates & Forecast, 2020-2027

9.4 Others

9.4.1 Market Estimates & Forecast, 2020-2027

10. Global Coma Diagnosis & Treatment Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12. Company Profiles

12.1 Fujifilm Holdings

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 GE Healthcare

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Siemens Healthcare

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Philips Healthcare

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Shimadzu Corporation

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Toshiba Medical Systems Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Carestream Health

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Coma Diagnosis & Treatment Industry Synopsis, 2020-2027

Table 2 Global Coma Diagnosis & Treatment Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Global Coma Diagnosis & Treatment Market by Region, 2020-2027, (USD Million)

Table 4 Global Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 5 Global Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 6 Global Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 7 Global Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 8 North America Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 9 North America Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 10 North America Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 11 North America Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 12 US Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 13 US Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 14 US Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 15 US Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 16 Canada Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 17 Canada Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 18 Canada Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 19 Canada Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 20 South America Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 21 South America Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 22 South America Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 23 South America Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 24 Europe Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 25 Europe Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 26 Europe Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 27 Europe Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 28 Western Europe Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 29 Western Europe Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 30 Western Europe Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 31 Western Europe Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 32 Eastern Europe Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 33 Eastern Europe Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 34 Eastern Europe Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 35 Eastern Europe Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 36 Asia Pacific Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 37 Asia Pacific Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 38 Asia Pacific Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 39 Asia Pacific Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

Table 40 Middle East & Africa Coma Diagnosis & Treatment Market by Types, 2020-2027, (USD Million)

Table 41 Middle East & Africa Coma Diagnosis & Treatment Market by Diagnosis, 2020-2027, (USD Million)

Table 42 Middle East & Africa Coma Diagnosis & Treatment Market by Treatment, 2020-2027, (USD Million)

Table 43 Middle East & Africa Coma Diagnosis & Treatment Market by End Users, 2020-2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Coma Diagnosis & Treatment Market

Figure 3 Segmentation Market Dynamics for Coma Diagnosis & Treatment Market

Figure 4 Global Coma Diagnosis & Treatment Market Share, by Diagnosis 2020

Figure 5 Global Coma Diagnosis & Treatment Market Share, by Treatment 2020

Figure 6 Global Coma Diagnosis & Treatment Market Share, by End Users, 2020

Figure 7 Global Coma Diagnosis & Treatment Market Share, by Region, 2020

Figure 8 North America Coma Diagnosis & Treatment Market Share, by Country, 2020

Figure 9 Europe Coma Diagnosis & Treatment Market Share, by Country, 2020

Figure 10 Asia Pacific Coma Diagnosis & Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa Coma Diagnosis & Treatment Market Share, by Country, 2020

Figure 12 Global Coma Diagnosis & Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Fujifilm Holdings: Key Financials

Figure 14 Fujifilm Holdings: Segmental Revenue

Figure 15 Fujifilm Holdings: Geographical Revenue

Figure 16 GE Healthcare: Key Financials

Figure 17 GE Healthcare: Segmental Revenue

Figure 18 GE Healthcare: Geographical Revenue

Figure 19 Siemens Healthcare: Key Financials

Figure 20 Siemens Healthcare: Segmental Revenue

Figure 21 Siemens Healthcare: Geographical Revenue

Figure 22 Philips Healthcare: Key Financials

Figure 23 Philips Healthcare: Segmental Revenue

Figure 24 Philips Healthcare: Geographical Revenue

Figure 25 Shimadzu Corporation.: Key Financials

Figure 26 Shimadzu Corporation: Segmental Revenue

Figure 27 Shimadzu Corporation: Geographical Revenue

Figure 28 Toshiba Medical Systems Corporation: Key Financials

Figure 29 Toshiba Medical Systems Corporation: Segmental Revenue

Figure 30 Toshiba Medical Systems Corporation: Geographical Revenue

Figure 31 Carestream Health.: Key Financials

Figure 32 Carestream Health: Segmental Revenue

Figure 33 Carestream Health: Geographical Revenue


Coma Diagnosis and Treatment Market Scenario


Coma refers to a state of unconsciousness in which a patient remains unresponsive to anything around them for a prolonged period of time. Depending on the severity of the coma, patient may require life-saving resuscitative measures and once the patient is medically stable, treatments can be used to treat original problem that is causing the coma.


There are various causes of coma such as traumatic brain injuries and are often caused by accidents or acts of violence. Strokes occur due to reduced or interrupted blood supply to the brain which is caused by blocked arteries or a burst blood vessel resulting in a coma. The other main cause of coma is tumors in the brain or brainstem. In some cases overdosing on drugs or alcohol can result in coma. Moreover, people with diabetes, blood sugar levels that become too high (hyperglycemia) or too low (hypoglycemia) causes coma. People who have been rescued from drowning or those who have been resuscitated after a heart attack may not awaken due to lack of oxygen to the brain. Furthermore infections such as encephalitis and meningitis cause swelling or inflammation of the brain, spinal cord or the tissues that surround the brain in severe cases of these infections can result in coma. Moreover, in some cases exposure to toxins, such as carbon monoxide or lead, can cause brain damage and coma.


Increasing prevalence of neurological disorders, increasing investment by biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the market. Moreover, favorable reimbursement policies, increased application and significant investments in the development of new technologies for the treatment of diseases will fuel the market growth during the forecast period


Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. 


According to the World Health Organization estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


However, limited availability of facilities and higher treatment cost may hamper the coma diagnosis & treatment market growth during the forecast period.


The coma diagnosis & treatment market is expected to grow at a CAGR of ~7.1% during the forecast period 2017-2023. 


Intended Audience



  • Pharmaceutical and Biotechnological Companies

  • Research and Development (R&D) Companies

  • Ambulatory Care Centers

  • Academic Institutes and Universities

  • Market Research and Consulting Service Providers

  • Potential Investors 


Figure: Coma Diagnosis & Treatment Market, By Region Market Share, 2016 (%) Coma Diagnosis and Treatment Market


Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The coma diagnosis & treatment market is segmented on the basis of types, diagnosis, treatment, and end user.


On the basis of the type, it is segmented into toxic- metabolic encephalopathy, anoxic brain injury, persistent vegetative state, locked-in syndrome, and brain death.  


On the basis of diagnosis it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, magnetic resonance imaging (MRI) and electroencephalography (EEG).


On the basis of treatment it is segmented into medical treatment, and others.


On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.


Regional Analysis


The Americas dominate the coma diagnosis & treatment market owing to well-developed technology, increasing patient population for brain disorder, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the coma diagnosis & treatment market in this region.


Europe holds the second position in the coma diagnosis & treatment market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such countries such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.     


Asia Pacific is the fastest growing coma diagnosis & treatment market owing to the presence of rapidly developing healthcare technology, increasing stressful life, and high healthcare expenditure. Moreover, increasing patient population in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the coma diagnosis & treatment market growth in this region.  


On the other hand, the Middle East & Africa holds the least share of the coma diagnosis & treatment market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa.


Key Players


Some of key the players in the market are Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Toshiba Medical Systems Corporation (Japan),   Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others. 


Research Methodology Global Coma Diagnosis and Treatment Market


Sources: Annual reports, Press release, White paper, and Company presentation


 


 



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

coma diagnosis & treatment market can expand at 7.1% CAGR from 2017 to 2023.

High prevalence of neurological disorders and the number of cases of coma are major drivers of the global coma diagnosis & treatment market.

High treatment costs and limited availability of the treatment are factors which can restrain market growth.

The Americas can dominate the global coma diagnosis & treatment market due to a large patient pool and favorable reimbursement policies.

APAC can display the highest growth rate in the global coma diagnosis & treatment market due to stressful lifestyle and rapidly developing healthcare infrastructure.

Siemens Healthcare, GE Healthcare, Hologic, Nihon Kohden Corporation, Toshiba Medical Systems Corporation, Shimadzu Corporation, Electrical Geodesics Inc., Fujifilm Holdings, Masimo Corporation, Esaote, Philips Healthcare, and Carestream Health are notable players of the global coma diagnosis & treatment market.